Other Events ·
TuHURA Biosciences held its 2026 Annual Meeting on August 18, 2026
HURATuHURA Biosciences, Inc.
TuHURA Biosciences held its 2026 Annual Meeting on August 18, 2026. Stockholders approved the issuance of 1,878,287 shares of common stock to Parkview Holdings One LLC as a loan fee under a $50 million revolving credit facility entered into in April 2026. The company also elected six directors: James Bianco, James Manuso, Alan List, George Ng, Robert E. Hoffman, and Craig Tendler. Shareholders ratified the advisory vote on executive compensation, selected a three-year frequency for future say-on-pay votes, and reappointed Cherry Bekaert LLP as independent auditor. These are routine governance actions without material financial impact. TuHURA Biosciences operates in the biotechnology industry, focusing on drug discovery.